Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Sacks

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2019
Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugsNed H Latham, Joseph S Doyle, Anna Y Palmer, et al.
Hepatology (Baltimore, Md.)|August 3, 2013
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infectionJason Grebely, Kimberly Page, Rachel Sacks-Davis, et al.
International Journal of Epidemiology|December 9, 2023
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)Daniela K van Santen, Ashleigh Stewart, Joseph S Doyle, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2024
Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International CohortBrendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
Eclinicalmedicine|January 9, 2023
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019Daniela K van Santen, Rachel Sacks-Davis, Ashleigh Stewart, et al.
The Lancet. HIV|January 15, 2024
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studiesRachel Sacks-Davis, Daniela K van Santen, Anders Boyd, et al.
BMJ Open|July 3, 2024
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocolJoseph S Doyle, Katherine Heath, Imogen Elsum, et al.
The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.
The Lancet. Infectious Diseases|November 3, 2018
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysisJack Stone, Hannah Fraser, Aaron G Lim, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2019
Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugsNed H Latham, Joseph S Doyle, Anna Y Palmer, et al.
Hepatology (Baltimore, Md.)|August 3, 2013
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infectionJason Grebely, Kimberly Page, Rachel Sacks-Davis, et al.
International Journal of Epidemiology|December 9, 2023
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)Daniela K van Santen, Ashleigh Stewart, Joseph S Doyle, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2024
Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International CohortBrendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
Eclinicalmedicine|January 9, 2023
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019Daniela K van Santen, Rachel Sacks-Davis, Ashleigh Stewart, et al.
The Lancet. HIV|January 15, 2024
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studiesRachel Sacks-Davis, Daniela K van Santen, Anders Boyd, et al.
BMJ Open|July 3, 2024
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocolJoseph S Doyle, Katherine Heath, Imogen Elsum, et al.
The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.
The Lancet. Infectious Diseases|November 3, 2018
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysisJack Stone, Hannah Fraser, Aaron G Lim, et al.
Pageof 12